News

The clearance is said to mark the company’s second 510(k) clearance and the first device on the market capable of treating an entire spectrum of disease found in

This open-label Phase IIa clinical trial is designed to evaluate an intravenous formulation of CK-1827452 in patients with stable heart failure undergoing clinically indicated coronary angiography in the

MedLink will now offer the complete range of Medicalis solutions to provide its radiology customers with clinical decision support for diagnostic imaging, as well as facilitated management of

Mr Paul has held CFO and vice president of finance positions with several manufacturers in agricultural machinery, hearing aids, and classic English knitwear. Horst Zerbe, president and CEO

Under the proposed terms of this arrangement, Huifeng will take over operational control of Qinba and will receive a management fee equal to all of Qinba’s profit. Jing’An

The company has also announced that Nawzer Mehta, vice president of clinical affairs, has tendered his resignation effective September 30, 2008 to pursue another opportunity. Ms Sheffield has

The Phase I trial will evaluate the safety and pharmacokinetics of a single intravenous dose of GMI-1070 at a range of dose levels. The initial Phase I trial

The clinical study will include patients with progressive, metastatic, hormone-refractory disease following prior taxane chemotherapy, and will assess the safety, tolerability and initial clinical activity of prostate-specific membrane

In April 2008, ESBATech initiated the Phase I study designed to evaluate the safety, tolerability and pharmacokinetic profile of ESBA105, when delivered topically via eye drops in healthy